Researchers at The Scripps Research Institute (TSRI) have developed a quick and easy way to simultaneously modify dozens of drugs or molecules to improve their disease-fighting properties. Using the approach, scientists exchanged one chemical group for another in 39 cancer drugs—and discovered under lab conditions that the chemically altered versions of three of the drugs had more potent anti-cancer activity.
The results, published today in the Journal of the American Chemical Society, reveal a powerful application of so-called “click chemistry” to drug discovery.
“Usually you have to make thousands or millions of molecules and go through a big screening process to find one or two molecules that are interesting and might work,” says Peng Wu, PhD, a TSRI associate professor and one of the study’s lead authors. “With this new approach, you can save time and money by starting with drugs and molecules you know are already active and asking whether a quick modification makes any of them any better.”
“Our results suggest we will be able take a drug and make it more potent, faster acting, and hopefully with better bioavailability,” adds Nobel laureate K. Barry Sharpless, PhD, who co-led the study.
Sharpless, the TSRI W.M. Keck Professor of Chemistry, first conceived of click chemistry in the 1990s. Click chemistry is the term for simple molecular reactions that can each be carried out in one container, undisturbed by water, and generate just one stable product at high yield. Sharpless compares the method to decorating molecules like Christmas trees, adding a new functional “ornament” to one of a molecule’s branches, which he calls “clickable hubs.”
“Instead of pursuing leads, which is the traditional method, SuFEx click chemistry is about connecting promising drug candidates directly with targets,” says Sharpless.
One of the latest click chemistry reactions developed by Sharpless’ group was Sulfur (VI) Fluoride Exchange (SuFEx), which transforms any phenol chemical group into a fluorosulfate. Because fluorosulfates have some benefits over phenols—including tighter binding to proteins, and less ability to be modified in the cell—the SuFEx reaction offers a way to potentially improve phenol drugs.
However, the transformation typically relies on sulfuryl fluoride gas, which makes it hard to perform on many different molecules at the same time; each reaction must be carried out in its own flask.
In the new paper, Sharpless and Wu show that sulfuryl fluoride gas can be dissolved in an organic solvent to make a liquid form of the reagent needed for SuFEx. “Now, suddenly, we can use this in high-throughput experiments,” says Wu.
To test the reaction’s utility in drug discovery, Sharpless, Wu and their colleagues put 39 existing cancer drugs containing phenols into plates, added the liquid version of sulfuryl fluoride to each well, and exposed cancer cells to both the original compounds and the resulting fluorosulfate versions. In three instances, the new fluorosulfate drug killed more cancer cells than the original version. When modified with SuFEx, the breast cancer drug Fulvestrant had a great effect on estrogen receptors in breast cancer cells, and the cancer drug Combretastatin A4 was 70 times more potent against colon cancer cells.
Upon further examination, the researchers discovered that the new molecules bound to their molecular targets better and were less apt to be metabolized by the cells.
“We think our approach is generally applicable to drug modification outside of just cancer drugs,” says Wu. The team is already using the new high-throughput SuFEx to modify drugs targeting the immune system’s T cells, he adds.
Learn more: ‘Click chemistry’ reactions may boost cancer-fighting drug potency
The Latest on: Click chemistry
- In Situ Click Chemistry For Antibiotics on August 23, 2018 at 6:58 am
I have always had a liking for the technique of having target proteins assemble their own inhibitors. This goes under several names: target-guided synthesis or protein-templated reactions more general... […]
- A New Gene Engineering Method Could Allow Us to Grow Organs for Transplants on September 12, 2017 at 12:26 pm
In a study published in the journal Nature Chemistry, the researchers showcased a purely chemical technique for gene assembly. It uses an efficient and rapid-acting chemical reaction called click chem... […]
- Making Polymer Chemistry ‘Click’ on July 25, 2017 at 6:19 am
A team of researchers has developed a faster and easier way to make sulfur-containing polymers that will lower the cost of large-scale production. The achievement, published in Nature Chemistry and An... […]
- Click chemistry enables preclinical evaluation of targeted epigenetic therapies on June 15, 2017 at 7:12 pm
1 Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, Australia. 2 Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. 3 Cellzome GmbH, ... […]
- Genetic engineering through click chemistry on May 31, 2017 at 8:24 am
SnapFect works via a bio-orthogonal reaction. First, ketone-decorated liposomes fuse into cell membranes, creating ketone-labeled cells. When nucleic acids or proteins are packaged into a complementar... […]
- Fluorinated azides click to make triazoles on December 18, 2016 at 2:55 pm
A two-step, one-pot reaction creates new fluorinated azides for copper-catalyzed fluorinated click chemistry. With the help of new fluorinating reagents, a team led by Zsófia E. Blastik and Petr Beier ... […]
- Click! That's how modern chemistry bonds nanoparticles to a substrate on March 18, 2015 at 5:00 pm
Nanoparticles of different types can be permanently and rapidly bonded to a substrate, if one of the most effective methods of synthesis, click chemistry, is used for this purpose. The novel method wa... […]
- Integrated Diagnostics Licenses "Click Chemistry" From The Scripps Research Institute, Stengthening Partner Network on October 25, 2011 at 5:00 pm
SEATTLE, WA--(Marketwire -10/26/11)- Integrated Diagnostics, an emerging leader in molecular diagnostics, today announced that it has signed a worldwide licensing agreement with The Scripps Research I... […]
- Click chemistry with copper -- a biocompatible version on July 17, 2011 at 5:00 pm
A version of click chemistry with an azide-based fluorophore (green star) and a BTTES-based copper catalyst was shown to be target specific, fast-working and safe for the fluorescent labeling og glyca... […]
- Scripps Research Institute and Aileron Therapeutics™ Enter Exclusive Worldwide Agreement to Utilize "Click" Chemistry for the Development of Stabilized Peptide and Protein ... on November 30, 2010 at 12:30 am
LA JOLLA, Calif. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--The Scripps Research Institute and Aileron Therapeutics™ today announced that they have entered into an agreement that will add Scripps Research’s ... […]
via Google News and Bing News